Home Cart 0 Sign in  
X

[ CAS No. 312-84-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 312-84-5
Chemical Structure| 312-84-5
Chemical Structure| 312-84-5
Structure of 312-84-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 312-84-5 ]

Related Doc. of [ 312-84-5 ]

Alternatived Products of [ 312-84-5 ]

Product Details of [ 312-84-5 ]

CAS No. :312-84-5 MDL No. :MFCD00004269
Formula : C3H7NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :MTCFGRXMJLQNBG-UWTATZPHSA-N
M.W : 105.09 Pubchem ID :71077
Synonyms :
(R)-Serine;NSC 77689
Chemical Name :H-D-Ser-OH

Calculated chemistry of [ 312-84-5 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 3.0
Molar Refractivity : 22.18
TPSA : 83.55 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.12 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.19
Log Po/w (XLOGP3) : -3.07
Log Po/w (WLOGP) : -1.61
Log Po/w (MLOGP) : -3.91
Log Po/w (SILICOS-IT) : -1.45
Consensus Log Po/w : -1.97

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 1.57
Solubility : 3950.0 mg/ml ; 37.5 mol/l
Class : Highly soluble
Log S (Ali) : 1.88
Solubility : 7970.0 mg/ml ; 75.9 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 1.3
Solubility : 2080.0 mg/ml ; 19.8 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.51

Safety of [ 312-84-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 312-84-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 312-84-5 ]
  • Downstream synthetic route of [ 312-84-5 ]

[ 312-84-5 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 1342309-23-2 ]
  • [ 17407-56-6 ]
  • [ 17407-55-5 ]
  • [ 312-84-5 ]
  • [ 56-45-1 ]
  • [ 20312-37-2 ]
  • [ 13748-90-8 ]
  • [ 3060-46-6 ]
  • [ 63-91-2 ]
  • [ 31321-74-1 ]
  • [ 673-06-3 ]
Reference: [1] Journal of Natural Products, 2011, vol. 74, # 10, p. 2137 - 2142
  • 2
  • [ 1342309-24-3 ]
  • [ 17407-56-6 ]
  • [ 17407-55-5 ]
  • [ 312-84-5 ]
  • [ 56-45-1 ]
  • [ 20312-37-2 ]
  • [ 13748-90-8 ]
  • [ 3060-46-6 ]
  • [ 63-91-2 ]
  • [ 31321-74-1 ]
  • [ 673-06-3 ]
Reference: [1] Journal of Natural Products, 2011, vol. 74, # 10, p. 2137 - 2142
  • 3
  • [ 312-84-5 ]
  • [ 501-53-1 ]
  • [ 6081-61-4 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hydrogencarbonate In water at 0 - 5℃;
Stage #2: at 0 - 20℃;
A solution of NaHCO3 (605 g, 5.72 mol) in water(3 l) was cooled to 0–5°C on an ice bath, and D-serine (200 g, 1.90 mol) was added in portions (8–10 portions with 20–30 min interval). Then 50percent solution of benzyl chloroformate in toluene (780 g, 2.29 mol) at 0–5°C was added dropwise over a 1 h period. Reaction mixture was stirred for 2 h at 0–5°C, then warmed up to room temperature and stirred for 2 h more. Then EtOAc (400 ml) was added and pH adjusted to 2.0 with hydrochloric acid.Product was extracted with EtOAc (2×800 ml). Combined exstracts were concentrated under reduced pressure up to~640 ml affording a suspension. Cyclohexane (1200 ml) was added and resulting mixture slurried for 6 h. The purified product was isolated by filtration and dried under reduced pressure at 50°C to afford compound 2. Yield432.5 g (95percent), white solid, mp 119–120°C (mp 119°C27),[α]D25 –5.08 (c 2.7, AcOH). IR spectrum, ν, cm–1: 1689(C=O), 1749 (C=O), 3319 (NH), 3338 (OH). UV spectrum, λmax, nm: 208. 1H NMR spectrum (CD3OD), δ, ppm(J, Hz): 3.83–3.92 (2H, m, CH2); 4.30 (1H, t, J = 8.8,NCH); 5.13 (2H, s, CH2); 7.29–7.40 (5H, m, H Ph). 13C NMR spectrum (CD3OD), δ, ppm: 57.7; 63.1; 67.7;128.9 (2C); 129.0; 129.5 (2C); 138.1; 158.6; 173.8. Massspectrum, m/z (Irel,percent): 238 [M–H] (100).
Reference: [1] Tetrahedron Letters, 2014, vol. 55, # 19, p. 3114 - 3116
[2] Chemistry of Heterocyclic Compounds, 2017, vol. 53, # 11, p. 1248 - 1253[3] Khim. Geterotsikl. Soedin., 2017, vol. 53, # 11, p. 1248 - 1253,6
[4] European Journal of Organic Chemistry, 2001, # 16, p. 3067 - 3074
[5] Asian Journal of Chemistry, 2011, vol. 23, # 11, p. 5169 - 5170
[6] Organic and Biomolecular Chemistry, 2018, vol. 16, # 8, p. 1343 - 1350
[7] Journal of Organic Chemistry, 2002, vol. 67, # 5, p. 1536 - 1547
[8] Angewandte Chemie - International Edition, 2017, vol. 56, # 16, p. 4549 - 4553[9] Angew. Chem., 2017, vol. 129, p. 4620 - 4624,5
[10] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4815 - 4830
[11] Journal of Organic Chemistry, 1985, vol. 50, # 19, p. 3676 - 3678
[12] Patent: WO2011/99033, 2011, A1, . Location in patent: Page/Page column 37-38
[13] Journal of Medicinal Chemistry, 2012, vol. 55, # 10, p. 4824 - 4836
[14] MedChemComm, 2013, vol. 4, # 5, p. 783 - 791
[15] Patent: WO2015/42397, 2015, A1, . Location in patent: Paragraph 000219
[16] Patent: WO2015/65937, 2015, A1, . Location in patent: Paragraph 000201
[17] Patent: WO2016/145153, 2016, A1, . Location in patent: Paragraph 000166
[18] Angewandte Chemie - International Edition, 2018, vol. 57, # 11, p. 2884 - 2888[19] Angew. Chem., 2018, vol. 130, # 11, p. 2934 - 2938,5
  • 4
  • [ 312-84-5 ]
  • [ 6081-61-4 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 2887,2890
[2] Journal of Biological Chemistry, 1955, vol. 212, p. 39,42
  • 5
  • [ 67-56-1 ]
  • [ 312-84-5 ]
  • [ 24424-99-5 ]
  • [ 95715-85-8 ]
Reference: [1] Helvetica Chimica Acta, 2007, vol. 90, # 2, p. 217 - 259
  • 6
  • [ 67-56-1 ]
  • [ 312-84-5 ]
  • [ 5874-57-7 ]
YieldReaction ConditionsOperation in experiment
97% at 20℃; for 24 h; Inert atmosphere 4.2.1.1
(R)-Methyl 2-isopropyl-4,5-dihydrooxazole-4-carboxylate
At first, SOCl2 (7.60 mL, 104.2 mmol) was added to d-serine (10.0 g, 95.1 mmol) in MeOH and allowed to react at room temperature for 24 h.
9a
Removal of the solvents left a white solid that upon washing with n-hexane (3 * 25 mL) provided the d-serine methylester HCl salt (14.4 g, 97percent) as a colourless solid. 1H NMR (300 MHz, D2O) δ 4.32-4.28 (1H, m, CH), 4.12 (1H, dd, J 4.2, 12.5 Hz, CHaHbOH), 4.02 (1H, dd, J 3.4, 12.5 Hz, CHaHbOH), 3.88 (3H, s, CH3).
96% at 20℃; for 12 h; Inert atmosphere Dichlorosulfoxide (18.68 g, 157.00 mmol) was slowly added dropwise to anhydrous salt-cooled anhydrous CH3OH (30 mL)under N2 protection. After the addition was completed, the reaction solution was warmed to room temperature and stirred for half an hour. Then, Compound 1 (5.00 g, 47.58 mmol) as described in the above reaction formula was added and reacted at room temperature for 12 hours, and the reaction solution became clear from turbidity. The reaction was concentrated and dried in vacuo to give a white solid: Compound 2 (7.10 g, 96percent).
96% at 5 - 20℃; for 4 h; 10 g of D-serine and 40 ml of methanol were placed in a reaction flask, 10 ml of thionyl chloride was added dropwise at 5±2 ° C, and reacted at room temperature for 4 hours. After the reaction was completed, it was concentrated to dryness.The crude cycloserine ester hydrochloride salt was 14.00 g.
95% at 0℃; for 2 h; Reflux General procedure: Acetyl chloride (1.6 mL, 22 mmol) was added to MeOH (100 mL), and the solution was cooled to 0°C. The solution was stirred for 5 min. Amino acid (L-serine, D-serine, L-cysteine, D-cysteine, L-2,3-diaminopropionic acid, and D-2,3-diaminopropionic acid) (20 mmol) was then added to the acetyl chloride solution in methanol (MeOH), and the solution was heated to reflux for 2 h, then cooled to room temperature.The reaction was evaporated under reduced pressure and gavea colorless solid. The solid was washed with CH2Cl2 (20 mL)to give amino acid methyl ester hydrochloride (2d–f, 2d–f)as a white solid. The yields of 2d, d, e, e, f and f were 95percent,96percent, 94percent, 96percent, 95percent, 95percent, respectively.
93% at -5 - 20℃; Inert atmosphere; Reflux; Green chemistry Dissolve 105.09g D-serine in 1.5L dry methanol and cool down to -50°C.With nitrogen protection, 178.46 g of thionyl chloride was added dropwise, and after completion of the addition, the reaction was allowed to warm to room temperature and stirred for 2 hours.Then continue to heat up to reflux, stirring and refluxing overnight, after the reaction is complete, the solvent is evaporated under reduced pressure,Ethyl acetate was washed by washing with suction to obtain 219 g of white solid D-serine methyl ester hydrochloride in 93percent yield.
67.75% at 0 - 20℃; for 16 h; Inert atmosphere To a stirred solution of D-serine (10 g, 95.23 mmol) in MeOH (100 mL) under an argon atmosphere was added thionylchloride (56.65 g, 476.19 mmol) at 0 oC. The reaction mixture was warmed to room temperature and stirred for 16 h. After consumption of the starting material (monitored by TLC), the volatile components were concentrated in vacuo. The crude material was washed with ether (2 x 100 mL) and dried in vacuo to obtain the methyl D-serinate hydrochloride (10 g, 67.75percent) as an off-white solid.1H-NMR (DMSO-d6, 500 MHz): δ 8.60-8.55 (m, 3H), 5.61-5.59 (m, 1H), 4.10-4.08 (m, 1H), 3.83-3.79 (m, 2H), 3.74 (s, 3H); TLC: 10percent MeOH/ CH2Cl2 (Rf: 0.3).
67.75% at 0 - 20℃; for 16 h; Inert atmosphere Synthesis of methyl D-serinate hydrochloride
To a stirred solution of D-serine (10 g, 95.23 mmol) in MeOH (100 mL) under an argon atmosphere was added thionylchloride (56.65 g, 476.19 mmol) at 0° C.
The reaction mixture was warmed to room temperature and stirred for 16 h.
After consumption of the starting material (monitored by TLC), the volatile components were concentrated in vacuo.
The crude material was washed with ether (2*100 mL) and dried in vacuo to obtain the methyl D-serinate hydrochloride (10 g, 67.75percent) as an off-white solid. 1H-NMR (DMSO-d6, 500 MHz): δ 8.60-8.55 (m, 3H), 5.61-5.59 (m, 1H), 4.10-4.08 (m, 1H), 3.83-3.79 (m, 2H), 3.74 (s, 3H); TLC: 10percent MeOH/CH2Cl2 (Rf: 0.3).

Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 2, p. 372 - 376
[2] Heterocyclic Communications, 2005, vol. 11, # 3-4, p. 343 - 346
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 15, p. 5716 - 5726
[4] Chemical Communications, 2016, vol. 52, # 55, p. 8612 - 8614
[5] Journal of Organic Chemistry, 2003, vol. 68, # 26, p. 10162 - 10165
[6] Organic Letters, 2013, vol. 15, # 10, p. 2474 - 2477
[7] Journal of Medicinal Chemistry, 2015, vol. 58, # 10, p. 4204 - 4219
[8] Journal of the Chemical Society, Perkin Transactions 1, 2000, # 12, p. 1837 - 1841
[9] Tetrahedron Letters, 2012, vol. 53, # 32, p. 4090 - 4092
[10] Tetrahedron: Asymmetry, 2012, vol. 23, # 18-19, p. 1350 - 1359,10
[11] Tetrahedron Asymmetry, 2012, vol. 23, # 18-19, p. 1350 - 1359
[12] Patent: CN107973830, 2018, A, . Location in patent: Paragraph 0033; 0047; 0049; 0051
[13] Patent: CN108558690, 2018, A, . Location in patent: Paragraph 0055; 0056; 0080; 0081
[14] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 1, p. 33 - 37
[15] Patent: CN107641087, 2018, A, . Location in patent: Paragraph 0018-0020; 0027
[16] Synthesis, 1993, # 2, p. 250 - 262
[17] Agricultural and Biological Chemistry, 1986, vol. 50, # 3, p. 615 - 624
[18] Tetrahedron Letters, 2014, vol. 55, # 19, p. 3114 - 3116
[19] Journal of the American Chemical Society, 2008, vol. 130, # 31, p. 10072 - 10073
[20] Patent: WO2015/109109, 2015, A1, . Location in patent: Paragraph 0775
[21] Patent: US2017/44182, 2017, A1, . Location in patent: Paragraph 1067
[22] Tetrahedron, 1990, vol. 46, # 20, p. 7263 - 7282
[23] Journal of Organic Chemistry, 1986, vol. 51, # 14, p. 2728 - 2735
[24] Journal of Organic Chemistry, 1985, vol. 50, # 17, p. 3133 - 3137
[25] Archiv der Pharmazie, 1993, vol. 326, # 2, p. 101 - 113
[26] Heterocycles, 1995, vol. 40, # 1, p. 261 - 270
[27] Journal of Medicinal Chemistry, 1996, vol. 39, # 9, p. 1907 - 1916
[28] Synthesis, 2002, # 17, p. 2616 - 2626
[29] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 12, p. 3259 - 3267
[30] Tetrahedron Letters, 2006, vol. 47, # 20, p. 3337 - 3339
[31] Organic letters, 2001, vol. 3, # 21, p. 3273 - 3275
[32] Tetrahedron Letters, 2010, vol. 51, # 49, p. 6381 - 6383
[33] Patent: WO2011/99033, 2011, A1, . Location in patent: Page/Page column 34-35
[34] Tetrahedron, 2011, vol. 67, # 48, p. 9426 - 9432
[35] Journal of Medicinal Chemistry, 2012, vol. 55, # 23, p. 10460 - 10474
[36] Angewandte Chemie - International Edition, 2015, vol. 54, # 5, p. 1537 - 1541[37] Angew. Chem., 2015, vol. 127, # 5, p. 1557 - 1561,5
[38] Organic Letters, 2018, vol. 20, # 12, p. 3574 - 3578
  • 7
  • [ 312-84-5 ]
  • [ 75-36-5 ]
  • [ 5874-57-7 ]
YieldReaction ConditionsOperation in experiment
91% for 15.5 h; Reflux Example-1
Preparation of D-Serine Methyl Ester Hydrochloride
D-serine (100 g, 0.9515 mole) was suspended in 600 ml methanol at room temperature.
Acetyl chloride (224.0 g, 2.8545 mole) was added drop wise at -5° C. to 0° C. and stirred for 30 minutes.
The reaction mixture was refluxed for 15 hours.
Evaporation of the reaction mixture under reduced pressure followed by crystallization of the resulting residue from methanol and methyl tert-butyl ether, resulted in colorless solid of D-serine methyl ester hydrochloride (134.7 g, Yield: 91percent, HPLC: 99.6percent) M.R: 165−167° C. (Lit.: 163−165° C., Tetrahedron Letters, 2012, 53, 1668-1670,)[α]D20=3.7 (C=4 in EtOH); IR(KBr): 3361, 2921, 2660, 2732, 2550, 2488, 2134, 2079, 1922, 1747, 1592, 1505, 1471, 1444, 1431, 1382, 1343, 1297, 1258, 1187, 1158, 1128, 1094, 1038, 969, 900, 793, 844, 580, 469 Cm−1; H1NMR: (300 MHz, DMSO), δ3.745 (s, 3H), 3.82 (s, 2H), 4.11 (s, 1H), 5.63 (s, 1H), 8.58 (s, 2H); 13CNMR: (300 MHz, DMSO), δ 52.66, 54.37, 59.38, 161.39.
Reference: [1] Patent: US9447024, 2016, B1, . Location in patent: Page/Page column 11
  • 8
  • [ 67-56-1 ]
  • [ 312-84-5 ]
  • [ 75-36-5 ]
  • [ 5874-57-7 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: for 0.0833333 h; Cooling with ice
Stage #2: for 2 h; Reflux
Acetyl chloride (4.06 mL, 57.14 mmol) was added to MeOH (100 mL) cooled in ice. The solution was stirred for 5 min. d-Serine (2 g, 19.04 ml) was added in one portion to a solution of d-serine in MeOH, and the solution was heated to reflux. The mixture was stirred for 2 h at reflux and cooled to room temperature. The reaction was evaporated under reduced pressure and gave a colorless solid. The solid was filtered and washed with CH2Cl2 (100 ml) to give d-serine methyl ester hydrochloride 2 (2.86 g, 97percent) as a white solid. mp 164-166 °C; -4 (c = 4.0, EtOH); 1H NMR (CD3OD, 300 MHz) δ 4.03 (m, 1H), 3.90 (dd, J = 6.6 Hz, J = 18.6 Hz, 1H), 3.82 (dd, J = 4.8 Hz, J = 17.4 Hz, 1H), 3.81 (s, 3H); 13C NMR (DMSO-d6, 75 MHz) δ 168.5, 59.5, 54.4, 52.8; HRMS (ESI) m/z (M+H)+ calculated for C4H10ClNO3 = 155.5801, found 155.4573.
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 13, p. 1668 - 1670
  • 9
  • [ 312-84-5 ]
  • [ 51887-88-8 ]
Reference: [1] Patent: US6372941, 2002, B1, . Location in patent: Example 5
  • 10
  • [ 312-84-5 ]
  • [ 24424-99-5 ]
  • [ 83345-44-2 ]
Reference: [1] MedChemComm, 2014, vol. 5, # 11, p. 1693 - 1699
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 312-84-5 ]

Amino Acid Derivatives

Chemical Structure| 1068-84-4

[ 1068-84-4 ]

Aminomalonic acid

Similarity: 0.96

Chemical Structure| 338-69-2

[ 338-69-2 ]

H-D-Ala-OH

Similarity: 0.91

Chemical Structure| 302-72-7

[ 302-72-7 ]

DL-Alanine

Similarity: 0.91

Chemical Structure| 56-41-7

[ 56-41-7 ]

H-Ala-OH

Similarity: 0.91

Chemical Structure| 6003-05-0

[ 6003-05-0 ]

(S)-2-Aminopropanoic acid hydrochloride

Similarity: 0.88